206 related articles for article (PubMed ID: 1873625)
1. The marketing of 5-hydroxytryptamine: depression or anxiety?
Healy D
Br J Psychiatry; 1991 Jun; 158():737-42. PubMed ID: 1873625
[No Abstract] [Full Text] [Related]
2. [Potential value of 5-HT2 receptor antagonists in the treatment of dysthymic disorders].
Sechter D; Bonin B; Bizouard P
Encephale; 1992 Dec; 18 Spec No 5():753-4. PubMed ID: 1342678
[No Abstract] [Full Text] [Related]
3. 5-HT-related, anxiety- and/or aggression-driven depression.
Van Praag HM
Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():5-6. PubMed ID: 7517413
[TBL] [Abstract][Full Text] [Related]
4. Is there action beyond receptors?
Hrdina PD
J Psychiatry Neurosci; 1993 Mar; 18(2):57-9. PubMed ID: 8384874
[No Abstract] [Full Text] [Related]
5. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
Benkert O; Wetzel H; Szegedi A
Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
[No Abstract] [Full Text] [Related]
6. Sleep patterns in depression and anxiety: theory and pharmacological effects.
Sandor P; Shapiro CM
J Psychosom Res; 1994; 38 Suppl 1():125-39. PubMed ID: 7799244
[TBL] [Abstract][Full Text] [Related]
7. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
Stahl SM
J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732
[TBL] [Abstract][Full Text] [Related]
8. The clinical utility of pharmacological agents that act at serotonin receptors.
Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
[TBL] [Abstract][Full Text] [Related]
9. Shifting depression.
Campbell IC; Marsden K; Powell JF
Psychol Med; 1994 May; 24(2):271-3. PubMed ID: 8084925
[No Abstract] [Full Text] [Related]
10. Serotonin selectivity for obsessive compulsive and panic disorders.
Montgomery SA; Bullock T; Fineberg N
J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
[No Abstract] [Full Text] [Related]
11. [Effects of antidepressants on symptoms, of inhibition].
de Carvalho W
Encephale; 1998; 24(5):456-61. PubMed ID: 9850820
[No Abstract] [Full Text] [Related]
12. Targeting opioid receptors: A new treatment for brain disorders.
Rahman S
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):128. PubMed ID: 20401980
[No Abstract] [Full Text] [Related]
13. Dysthymia and serotonin.
Lapierre YD; Ravindran A; Bakish D
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():87-90. PubMed ID: 8201250
[No Abstract] [Full Text] [Related]
14. Depression and 5HT.
Deakin JF
Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():23-8; discussion 29-31. PubMed ID: 1806632
[TBL] [Abstract][Full Text] [Related]
15. Serotonin: la chica de moda in biological psychiatry?
Banki CM
Biol Psychiatry; 1991 May; 29(10):949-52. PubMed ID: 2065139
[No Abstract] [Full Text] [Related]
16. Behavioral pharmacology: potential antidepressant and anxiolytic properties.
Wesołowska A; Jastrzębska-Więsek M
Int Rev Neurobiol; 2011; 96():49-71. PubMed ID: 21329784
[No Abstract] [Full Text] [Related]
17. Serotonin-specific drugs for anxiety and depressive disorders.
Charney DS; Krystal JH; Delgado PL; Heninger GR
Annu Rev Med; 1990; 41():437-46. PubMed ID: 2139556
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of 5-HT receptors during long-term antidepressant treatment and at discontinuation].
Fillion G
Encephale; 1995 Feb; 21 Spec No 1():3-6. PubMed ID: 7729352
[No Abstract] [Full Text] [Related]
19. Independent evaluation of new drugs.
Ball CJ
Br J Psychiatry; 1991 Oct; 159():586-7. PubMed ID: 1661200
[No Abstract] [Full Text] [Related]
20. Serotonin receptor subtypes: implications for psychopharmacology.
Cowen PJ
Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
